Djordjević V B, Pavlović D, Pejović M, Cvetković T, Lecić N, Deljanin-Ilić M
Institute of Biochemistry, Faculty of Medicine, Nis, Yugoslavia.
Clin Nephrol. 1997 Apr;47(4):243-7.
In 14 patients (4 males and 10 females) with systemic hypertension plasma and erythrocyte lipid peroxides, plasma and erythrocyte catalase activity, plasma glutathione S-transferase (GST) activity, blood reduced glutathione (GSH) content and erythrocyte oxidant stress were investigated. All parameters were performed after clinical examination and then the patients were assigned to receive ACE inhibitor therapy, captopril (25-50 mg given twice per day) or enalapril (10-40 mg given twice per day). After six months the determination of lipid peroxides and antioxidative factors was repeated. At the beginning of the study both treated groups showed significantly higher plasma lipid peroxides compared to the control group. Both used ACE inhibitors produced significant decrease of plasma lipid peroxides after six months. Blood GSH content was also significantly higher in both patient groups before the treatment compared to the controls. Neither captopril nor enalapril produced any significant effect on GSH. Initial values of plasma GST activity in the patients were similar to the control group and did not significantly change after six month treatment. The patients assigned to receive enalapril showed significantly enhanced initial plasma catalase activity according to the controls. After six months treatment both ACE inhibitors significantly decreased plasma catalase activity. Erythrocyte lipid peroxides, erythrocyte catalase activity and oxidant stress of erythrocytes in both groups studied neither differ significantly at initial time of investigation according to the control group nor during or after six month treatment.
对14例(4例男性和10例女性)系统性高血压患者的血浆和红细胞脂质过氧化物、血浆和红细胞过氧化氢酶活性、血浆谷胱甘肽S - 转移酶(GST)活性、血液还原型谷胱甘肽(GSH)含量以及红细胞氧化应激进行了研究。所有参数均在临床检查后测定,然后将患者分为接受ACE抑制剂治疗组,卡托普利(每日两次,每次25 - 50毫克)或依那普利(每日两次,每次10 - 40毫克)。六个月后重复测定脂质过氧化物和抗氧化因子。在研究开始时,两个治疗组的血浆脂质过氧化物均显著高于对照组。两种使用的ACE抑制剂在六个月后均使血浆脂质过氧化物显著降低。治疗前两个患者组的血液GSH含量也显著高于对照组。卡托普利和依那普利对GSH均未产生任何显著影响。患者血浆GST活性的初始值与对照组相似,六个月治疗后无显著变化。与对照组相比,接受依那普利治疗的患者初始血浆过氧化氢酶活性显著增强。六个月治疗后,两种ACE抑制剂均使血浆过氧化氢酶活性显著降低。研究的两组患者的红细胞脂质过氧化物、红细胞过氧化氢酶活性以及红细胞氧化应激在研究初始时与对照组相比均无显著差异,在六个月治疗期间及治疗后也无显著差异。